Skip NavigationSkip to Content

The stability of monomeric intermediates controls amyloid formation: A beta 25-35 and its N27Q mutant

  1. Author:
    Ma, B. Y.
    Nussinov, R.
  2. Author Address

    NCI, Basic Res Program, SAIC Frederick, Ctr Canc Res,Nanobiol Program,FCRDC, Frederick, MD 21702 USA. Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, Sackler Inst Mol Med, IL-69978 Tel Aviv, Israel.;Ma, BY, NCI, Basic Res Program, SAIC Frederick, Ctr Canc Res,Nanobiol Program,FCRDC, Frederick, MD 21702 USA.;mab@ncifcrf.gov ruthn@ncifcrf.gov
    1. Year: 2006
    2. Date: May
  1. Journal: Biophysical Journal
    1. 90
    2. 10
    3. Pages: 3365-3374
  2. Type of Article: Article
  3. ISSN: 0006-3495
  1. Abstract:

    The structure and stabilities of the intermediates affect protein folding as well as misfolding and amyloid formation. By applying Kramer's theory of barrier crossing and a Morse-function-like energy landscape, we show that intermediates with medium stability dramatically increase the rate of amyloid formation; on the other hand, very stable and very unstable intermediates sharply decrease amyloid formation. Remarkably, extensive molecular dynamics simulations and conformational energy landscape analysis of A beta 25 - 35 and its N27Q mutant corroborate the mathematical description. Both experimental and current simulation results indicate that the core of the amyloid structure of A beta 25 - 35 formed from residues 28 - 35. A single mutation of N27Q of A beta 25 - 35 makes the A beta 25 - 35 N27Q amyloid-free. Energy landscape calculations show that A beta 25 - 35 has extended intermediates with medium stability that are prone to form amyloids, whereas the extended intermediates for A beta 25 - 35 N27Q split into stable and very unstable species that are not disposed to form amyloids. The results explain the contribution of both alpha-helical and beta-strand intermediates to amyloid formation. The results also indicate that the structure and stability of the intermediates, as well as of the native folded and the amyloid states can be targeted in drug design. One conceivable approach is to stabilize the intermediates to deter amyloid formation.

    See More

External Sources

  1. DOI: 10.1529/biophysj.105.075309
  2. WOS: 000236901400004

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel